play_arrow

keyboard_arrow_right

replay_10 skip_previous play_arrow skip_next forward_10
00:00 00:00
playlist_play chevron_left
volume_up
play_arrow

The Dolo Debate – Is Pharma Paying for Prescriptions?

Kiran Somvanshi August 25, 2022


Background
share close

Dolo650 became a household medicine during the pandemic. … but the latest controversy of freebies being given to promote it has yet again brought the spotlight on the questionable marketing practices of pharma companies. Host Kiran Somvanshi probed the issue with stakeholders – Dr. Viranchi Shah, National President, Indian Drug Manufacturers Association (IDMA), Malini Aisola, National Co-convenor of All India Drug Action Network (AIDAN), Santanu Chatterjee, General Secretary of Federation of Medical and Sales Representatives’ Association of India (FMRAI) and Vikas Dandekar, Editor – Pharma & Healthcare at ET Prime. Credits: CNBC TV18, WION and Medical Dialogues Youtube Channel.

Credits : Producer - Sumit Pande from The Economic Times and Soundarya Jayachandran from Aawaz. Sound Editor - Rajas Naik from The Economic Times and Swati Joshi from Aawaz. Executive producers: Anupriya Bahadur and Arijit Barman from The Economic Times.